ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
MedEnvision, a Belgium-based medtech provider, received a majority investment from TA Associates. Existing shareholders including CEO Dries Goyens and Smile Invest also participated. The deal amount was not disclosed. The company plans to use funds for international expansion and broadening its product portfolio.
Tap to vote and see what everyone thinks.
Summary by ByteBrief